These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25115540)

  • 1. Metabotropic glutamate receptor 5 in Down's syndrome hippocampus during development: increased expression in astrocytes.
    Iyer AM; van Scheppingen J; Milenkovic I; Anink JJ; Lim D; Genazzani AA; Adle-Biassette H; Kovacs GG; Aronica E
    Curr Alzheimer Res; 2014; 11(7):694-705. PubMed ID: 25115540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
    Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
    Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains.
    Oka A; Takashima S
    Acta Neuropathol; 1999 Mar; 97(3):275-8. PubMed ID: 10090675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.
    Busciglio J; Pelsman A; Wong C; Pigino G; Yuan M; Mori H; Yankner BA
    Neuron; 2002 Feb; 33(5):677-88. PubMed ID: 11879646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR Hyperactivation in down syndrome hippocampus appears early during development.
    Iyer AM; van Scheppingen J; Milenkovic I; Anink JJ; Adle-Biassette H; Kovacs GG; Aronica E
    J Neuropathol Exp Neurol; 2014 Jul; 73(7):671-83. PubMed ID: 24918639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains.
    Saito Y; Oka A; Mizuguchi M; Motonaga K; Mori Y; Becker LE; Arima K; Miyauchi J; Takashima S
    Acta Neuropathol; 2000 Dec; 100(6):654-64. PubMed ID: 11078217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.
    Stoltzner SE; Grenfell TJ; Mori C; Wisniewski KE; Wisniewski TM; Selkoe DJ; Lemere CA
    Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology.
    Sadowski M; Wisniewski HM; Tarnawski M; Kozlowski PB; Lach B; Wegiel J
    Acta Neuropathol; 1999 Feb; 97(2):156-64. PubMed ID: 9928826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental distribution pattern of metabotropic glutamate receptor 5 in prenatal human hippocampus.
    Yang P; Zhang J; Zhao L; Jiao Q; Jin H; Xiao X; Zhang H; Hu M; Lu H; Liu Y
    Neurosci Bull; 2012 Dec; 28(6):704-14. PubMed ID: 23225313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.
    Helguera P; Pelsman A; Pigino G; Wolvetang E; Head E; Busciglio J
    J Neurosci; 2005 Mar; 25(9):2295-303. PubMed ID: 15745955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic and histochemical development and ageing in patients with Down's syndrome.
    Takashima S; Iida K; Mito T; Arima M
    J Intellect Disabil Res; 1994 Jun; 38 ( Pt 3)():265-73. PubMed ID: 8061472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.
    Armstrong RA
    Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STARD1 and NPC1 expression as pathological markers associated with astrogliosis in post-mortem brains from patients with Alzheimer's disease and Down syndrome.
    Arenas F; Castro F; Nuñez S; Gay G; Garcia-Ruiz C; Fernandez-Checa JC
    Aging (Albany NY); 2020 Jan; 12(1):571-592. PubMed ID: 31902793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of E2F-1 in Down's syndrome brain exhibiting neuropathological features of Alzheimer-type dementia.
    Motonaga K; Itoh M; Hirayama A; Hirano S; Becker LE; Goto Y; Takashima S
    Brain Res; 2001 Jun; 905(1-2):250-3. PubMed ID: 11423103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology.
    Nagy Z; Esiri MM; LeGris M; Matthews PM
    Acta Neuropathol; 1999 Apr; 97(4):346-54. PubMed ID: 10208273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-β and Alzheimer's disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions.
    Grolla AA; Sim JA; Lim D; Rodriguez JJ; Genazzani AA; Verkhratsky A
    Cell Death Dis; 2013 May; 4(5):e623. PubMed ID: 23661001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB.
    Lim D; Iyer A; Ronco V; Grolla AA; Canonico PL; Aronica E; Genazzani AA
    Glia; 2013 Jul; 61(7):1134-45. PubMed ID: 23616440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.